RIPK1 is not essential for TNFR1-induced activation of NF-kappa B
WW-L Wong, IE Gentle, U Nachbur, H Anderton, DL Vaux, J Silke
Cell Death Differ. | NATURE PUBLISHING GROUP | Published : 2010
Awarded by NHMRC
Awarded by Leukemia and Lymphoma Society
We thank Michelle Kelliher for providing RIPK1<SUP>-/-</SUP> mice; Heinrich Korner for providing TNFR1<SUP>-/-</SUP> and TNFR2<SUP>-/-</SUP> mice; M McKinlay for supplying IAP antagonist, comp A (TetraLogic Pharmaceuticals); JE Vince for critical reading of the paper. JS is funded by the NHMRC (433013, 541901 and 541902). DLV is an NHMRC Australian Fellow, funded by the Leukemia and Lymphoma Society and the NHMRC (461221). IEG is funded by NHMRC Australian Postdoctoral Training Fellowship (487348). UN is funded by Swiss National Science Foundation.